2,124 Shares in CVS Health Co. (NYSE:CVS) Acquired by WealthPlan Investment Management LLC

WealthPlan Investment Management LLC bought a new position in shares of CVS Health Co. (NYSE:CVS – Get Rating) in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor bought 2,124 shares of the pharmacy operator’s stock, valued at approximately $217,000.

A number of other institutional investors and hedge funds have also recently bought and sold shares of the business. Vanguard Group Inc. increased its position in CVS Health by 1.5% during the 3rd quarter. Vanguard Group Inc. now owns 115,934,841 shares of the pharmacy operator’s stock worth $11,056,706,000 after purchasing an additional 1,726,512 shares in the last quarter. Charles Schwab Investment Management Inc. grew its position in CVS Health by 1.2% in the first quarter. Charles Schwab Investment Management Inc. now owns 11,699,284 shares of the pharmacy operator’s stock valued at $1,184,085,000 after acquiring an additional 134,457 shares in the last quarter. Legal & General Group Plc grew its position in CVS Health by 2.2% in the second quarter. Legal & General Group Plc now owns 10,321,160 shares of the pharmacy operator’s stock valued at $956,359,000 after acquiring an additional 220,516 shares in the last quarter. Nordea Investment Management AB grew its position in CVS Health by 38.6% in the second quarter. Nordea Investment Management AB now owns 9,680,490 shares of the pharmacy operator’s stock valued at $899,511,000 after acquiring an additional 2,697,382 shares in the last quarter. Finally, Boston Partners grew its position in CVS Health by 15.5% in the third quarter. Boston Partners now owns 8,034,788 shares of the pharmacy operator’s stock valued at $766,750,000 after acquiring an additional 1,077,638 shares in the last quarter. Institutional investors and hedge funds own 77.29% of the company’s stock.

CVS Health Stock Performance

CVS stock opened at $74.37 on Friday. The company has a debt-to-equity ratio of 0.71, a quick ratio of 0.67 and a current ratio of 0.94. The stock has a market capitalization of $95.50 billion, a price-to-earnings ratio of 23.84, a PEG ratio of 1.17 and a beta of 0.65. CVS Health Co. has a 1 year low of $73.91 and a 1 year high of $109.69. The stock’s fifty day moving average is $85.40 and its two-hundred day moving average is $93.04.

CVS Health (NYSE:CVS – Get Rating) last posted its earnings results on Wednesday, February 8th. The pharmacy operator reported $1.99 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.92 by $0.07. The company had revenue of $83.85 billion for the quarter, compared to analysts’ expectations of $76.37 billion. CVS Health had a return on equity of 15.75% and a net margin of 1.29%. The firm’s quarterly revenue was up 9.5% compared to the same quarter last year. During the same period last year, the business posted $1.98 earnings per share. On average, research analysts predict that CVS Health Co. will post 8.84 EPS for the current year.

CVS Health Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Monday, May 1st. Shareholders of record on Friday, April 21st will be paid a $0.605 dividend. This represents a $2.42 dividend on an annualized basis and a yield of 3.25%. The ex-dividend date of this dividend is Thursday, April 20th. CVS Health’s payout ratio is 77.56%.

Analyst Ratings Changes

Several analysts have issued reports on CVS shares. Royal Bank of Canada reaffirmed an “outperform” rating and issued a $115.00 price objective on shares of CVS Health in a research report on Thursday, February 9th. Morgan Stanley increased their price objective on shares of CVS Health from $119.00 to $120.00 and gave the company an “overweight” rating in a research report on Friday, January 13th. Credit Suisse Group raised their price target on shares of CVS Health from $117.00 to $125.00 and gave the stock an “outperform” rating in a research report on Monday, November 21st. Raymond James decreased their price target on shares of CVS Health from $115.00 to $110.00 and set an “outperform” rating for the company in a research report on Thursday, February 9th. Finally, Jefferies Financial Group raised their price target on shares of CVS Health from $130.00 to $143.00 and gave the stock a “buy” rating in a research report on Thursday, February 9th. Three analysts have rated the stock with a hold rating and fourteen have given a buy rating to the company. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $119.65.

CVS Health Company Profile

(Get Rating)

CVS Health Corp. is a health solutions company, which engages in the provision of healthcare services. It operates through the following segments: Pharmacy Services, Retail or Long-Term Care, Health Care Benefits, and Corporate and Other. The Pharmacy Services segment focuses on the pharmacy benefit management solutions.